Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/10/2002US20020147320 Novel human kinase proteins and polynucleotides encoding the same
10/10/2002US20020147315 Method for removing endotoxin from the samples containing basic protein
10/10/2002US20020147312 Hybrid antibody for use in the treatment, diagnosis and prevention of cancer and immunological disorders
10/10/2002US20020147310 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases
10/10/2002US20020147309 Human N-type calcium channel isoform and uses thereof
10/10/2002US20020147308 Human vomeronasal receptor
10/10/2002US20020147307 Therapeutic and diagnostic agents comprising a socs box
10/10/2002US20020147305 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002US20020147172 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
10/10/2002US20020147169 In vivo selection method for determining inhibitory RNA molecules
10/10/2002US20020147168 For plants
10/10/2002US20020147166 Antisense modulation of Talin expression
10/10/2002US20020147165 Antisense modulation of calreticulin expression
10/10/2002US20020147164 Antisense modulation of cytohesin-1 expression
10/10/2002US20020147163 Antisense modulation of casein kinase 2-alpha expression
10/10/2002US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020147145 Anticancer, antiproliferative agents
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020147136 Tetrapeptide
10/10/2002US20020147132 Meltrins
10/10/2002US20020147129 Polypeptides; nervous system, brain disorders
10/10/2002US20020146846 Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
10/10/2002US20020146831 High efficiency transfection based on low electric field strength, long pulse length
10/10/2002US20020146830 Methods and compositions for delivery of pharmaceutical agents
10/10/2002US20020146828 Microparticles and methods for delivery of recombinant viral vaccines
10/10/2002US20020146827 Expression vector for use as genetic engineering tool in the amplification of prefeerential products
10/10/2002US20020146825 Surface transfection and expression procedure
10/10/2002US20020146824 Novel transcription enhancer element and transcription factor and methods of use thereof
10/10/2002US20020146821 Bone marrow cells as a source of neurons for brain and spinal cord repair
10/10/2002US20020146820 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
10/10/2002US20020146819 Human TSLP DNA and polypeptides
10/10/2002US20020146810 Nucleotide sequences coding polypeptide for use in the treatment of mammary gland and bone marrow metastasis, pain, arthritis, depression and hematopoietic disorders
10/10/2002US20020146806 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and autoimmune diseases
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146804 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
10/10/2002US20020146803 Mutant protein for use as tool in genetic engineering
10/10/2002US20020146802 Methods for producing and purifying recombinant alpha-L-iduronidase
10/10/2002US20020146801 RNA polymerase I transcription factor TIF-IA
10/10/2002US20020146800 48921, a novel human GTP releasing factor and uses therefor
10/10/2002US20020146798 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders
10/10/2002US20020146797 Genetically engineered enzyme for use in the treatment of cell proliferative disorders
10/10/2002US20020146794 Recombinant human serum transferrins containing peptides for inducing apoptosis in HIV-1 infected cells
10/10/2002US20020146793 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
10/10/2002US20020146792 Nucleotide sequences coding protein for use in the treatment of atherosclerosis
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146785 Novel Escherichia coli having accession no PTA 1579 and its use to produce polyhydroxybutyrate
10/10/2002US20020146781 Nucleotide sequences coding for the thrE gene and process for the enzymatic production of L-threonine using coryneform bacteria
10/10/2002US20020146780 Generating preferential nucleotide sequences; obtain nucleotide sequences, incubate with primer, amplify, recover nucletide sequence products
10/10/2002US20020146779 Methods for production of recombinant polypeptides
10/10/2002US20020146775 Novel semaphorin genes (I)
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146771 Process for producing erythropoietin containing no animal proteins
10/10/2002US20020146770 RAS proteins
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146766 Human vomeronasal receptor-3
10/10/2002US20020146765 Acetylcholine receptor subunits
10/10/2002US20020146764 Generation of preferential polypeptides; obtain expresion vector containing preferential fusion gene, express vector, recover fusion protein
10/10/2002US20020146763 Polypeptide for use in the human therapeutic and diagnostics
10/10/2002US20020146762 Generating mutant polypeptides; obtain protein sample, incubate wih mutagen, recover and evaluate protein activity
10/10/2002US20020146760 G protein-coupled receptor for use in treatment of alzheimer's disease
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146757 Nucleotide sequences coding polypeptide for use in the treatment of, muscle, blood, nervous system, gastrointestinal and vision defects
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146739 Method for the affinity isolation of newly synthesized RNA
10/10/2002US20020146738 Nucleotide sequences coding polypeptides for use in the treatment and prevention of infections
10/10/2002US20020146733 Linear and circular expression elements
10/10/2002US20020146732 Method of increasing complementarity in a heteroduplex
10/10/2002US20020146731 Nucleotide sequences coding polypeptide for use as tool in genetic engineering
10/10/2002US20020146717 Probes for use as tool in detection of Cryptosporidium
10/10/2002US20020146716 Electrochemical sensor using intercalative, redox-active moieties
10/10/2002US20020146715 Spotting probe preferentially bound to solid support; obtain liquid containing probe, apply to surface of solid support, allow stain to form on solid support
10/10/2002US20020146710 Detecting preferental polypeptide in sample; obtain cells, transform with vector, recover transformed cells, monitor and evaluate gene expression in transformed cells
10/10/2002US20020146704 Reagent for use in the analysis and determination of nucleotide sequences
10/10/2002US20020146700 Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype
10/10/2002US20020146698 Kits and methods for assessing oxidative stress
10/10/2002US20020146696 Dry solid medium for storage and analysis of genetic material
10/10/2002US20020146695 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
10/10/2002US20020146693 Isolation and identification of secreted proteins
10/10/2002US20020146691 Detecting gene asociated with preferential phenotype; obtain preferential nucleotide sequences, transduce cells, culture cells, recover cell of preferential phenotype, monitor gene expression in recovered cells
10/10/2002US20020146690 Detecting preferential nucleotide sequences in sample; obtain nucleotide sequences, incubate with primers, detect signal determining the degree of hybridization
10/10/2002US20020146689 Dna expression in transfected cells and assays carried out in transfected cells
10/10/2002US20020146687 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
10/10/2002US20020146685 Kit for use in the accurate detection of viral infections
10/10/2002US20020146683 Modified hiv env polypeptides
10/10/2002US20020146679 Method for creating endothelial cell dysfunction in cell culture
10/10/2002US20020146678 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
10/10/2002US20020146434 As vaccine or gene vaccine; diagnostic reagent capable of accurately detecting infections with an epidemic strain of measles virus
10/10/2002US20020146430 Use of ClyA hemolysin for excretion of proteins
10/10/2002US20020146429 Live vaccines for allergy treatment
10/10/2002US20020146427 DNA encoding bovine immunoglobulin a inducing protein and uses therefor
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146418 For use in therapy
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146411 Anticoagulant agents useful in treatment of thrombosis
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146407 For therapy and prophylaxis of dysfunctions or diseases including, but not limited to, asthma, airway allergy, chronic obstructive pulmonary disease
1 ... 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 ... 4023